Skip to content

Virtual Rehabilitation Platform for Patients With Knee Prothesis

A Randomized Clinical Trial to Evaluate the Effectiveness of Telerehabilitation With Trak in Combination With the Traditional Treatment in Patients Who Have Undergone Knee Prothesis Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06720779
Enrollment
20
Registered
2024-12-06
Start date
2024-06-05
Completion date
2025-07-05
Last updated
2024-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthropathy

Keywords

telerehabilitation, telemedicine, exercise prescription, exercise program, knee replacement

Brief summary

This clinical trial aims to evaluate the effectiveness and usability of the Trak Rehabilitation Platform in patients who have undergone knee replacement surgery. Its main questions are whether the Trak platform combined with conventional therapy helps patients achieve optimal functionality with fewer in-person sessions compared to conventional rehabilitation alone and whether the Trak platform improves adherence to treatment, independence in daily activities, and quality of life while reducing resource consumption. Researchers will compare the use of the Trak platform combined with conventional rehabilitation to standard rehabilitation practices to determine its impact on functional outcomes, patient and provider satisfaction, and resource efficiency. Participants will: * Use the Trak Platform as part of their personalized treatment plan. * Attend face-to-face rehabilitation sessions as prescribed. * Participate in assessments to measure functionality, adherence, independence, quality of life, and resource utilization.

Detailed description

This randomized, controlled, single-center clinical trial conducted at Cruces University Hospital focuses on enhancing recovery outcomes by integrating telerehabilitation into conventional therapy. The trial involves two parallel groups: an experimental group (EG) using the TRAK platform and conventional face-to-face rehabilitation and a control group (CG) undergoing the last methodology (conventional rehabilitation) alone. Participants in the EG will perform four weekly 30-minute at-home sessions on the TRAK platform, which utilizes artificial intelligence for real-time movement guidance, posture correction, and gamified motivation. Conventional therapy in both groups includes bi-weekly sessions of cryotherapy, joint mobilization, strength exercises, and gait re-education. This hybrid approach aims to personalize care, optimize functionality, and reduce the required face-to-face sessions. Primary outcomes focus on reducing on-site rehabilitation sessions needed for functional recovery, while secondary outcomes assess adherence, independence, quality of life, and patient satisfaction. Data will be collected through validated questionnaires, biomechanical tests, and metrics from the TRAK system during baseline and four follow-up visits at 2, 4, 6, and 12 weeks. Healthcare professionals will receive training to ensure the effective use of the TRAK system. Ethical approval has been secured, and all participants will provide informed consent, ensuring compliance with the Declaration of Helsinki and GDPR. This study seeks to validate the TRAK platform's integration into clinical practice as a cost-effective and scalable solution to improve musculoskeletal rehabilitation outcomes. The findings will contribute to advancing digital health solutions in post-surgical recovery by exploring their usability and clinical impact.

Interventions

OTHERTRAK physio knee prosthesis protocol

The exercise protocol designed for knee conditions is carried out through TRAK, the digital rehabilitation tool.

Exercise protocol with the methodology of conventional clinical practice.

Sponsors

Biocruces Bizkaia Health Research Institute
CollaboratorOTHER_GOV
Trak Health Solutions S.L.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Twenty patients will be randomly assigned to the experimental or control group in a 1:1 ratio. Opaque envelopes containing the randomization sequence will be prepared to maintain allocation concealment. Patients meeting the inclusion criteria and agreeing to participate will be consecutively recruited. Experimental Group (EG): * Participants receive standard face-to-face rehabilitation twice a week, which involves 25 minutes of conventional rehabilitation (cryotherapy, joint mobilization, strength training, and gait re-education) and 20 minutes of gait exercises. * Additionally, they perform four weekly 30-minute rehabilitation sessions at home using the TRAK platform. * The TRAK platform incorporates advanced AI for movement tracking, gamification features, and personalized exercise routines. Control Group (CG): Participants receive only the conventional rehabilitation protocol.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged \>18 and ≤85 years. * Patients who underwent surgery for the implantation of a knee prosthesis at the Knee Unit of the Cruces University Hospital. * Patients who require on-site rehabilitation at the Cruces university hospital rehabilitation service. * Patients who have signed the Informed Consent.

Exclusion criteria

* Patients with intellectual disability or cognitive impairment. * Patients with a history of knee infection. * Patients who cannot make use of mobile applications, cell phones, tablets, laptops or e- mail and who do not have the support of a family member or caregiver to provide support to make use of these technologies. * Patients who have not signed the Informed Consent.

Design outcomes

Primary

MeasureTime frameDescription
Number of face-to-face rehabilitation sessions required for each patient to reach the optimal level of function for dischargeVisit 5 (week 12)Sessions required to reach the next criteria: * Muscle balance = 4 in quadriceps and hamstrings according to the Medical Research Council (MRC). * Joint balance between 0-100 degrees of flexion, measured by goniometer * VAS scale \<4 * Stable gait

Secondary

MeasureTime frameDescription
Knee flexion articular balanceVisits 1 (week 1) to 5 (week 12) for both groupsKnee flexion range of motion measured with a goniometer
TRAK platform knee flexion testVisits 1 (week 1) to 5 (week 12) only on the intervention groupKnee flexion measured by video on the TRAK platform
MRC (Medical Research Council) scaleVisits 1 (week 1) to 5 (week 12) for both groupsStrength test for the cuadriceps muscle. The results go from Grade 5 (normal) to Grade 0 (no visible contraction).
10 meter walk testvisits 2 (Week 2) and 5 (Week 12) for both goupsTime and speed in 10 meter walk
6 minute walk testvisits 2 (Week 2) and 5 (Week 12) for both goupsDistance covered on a 6 minute walk
Up and go testvisits 2 (Week 2) and 5 (Week 12) for both goupsthe time, in seconds, it takes for an individual to get up from a standard chair, walk a distance of 3 meters, turn around, walk back to the chair and sit down again.
WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index)visits 1 (Week 1) and 5 (Week 12) for both goupsLife quality questionnaire. The results go from 0 to 98 being 0 the worst life quality and 98 the best.
VAS scalevisits 1 (week 1) to 5 (week 2) for both goupsScale used by the patient to measure pain from 1 to 10 being 1 no pain and 10 the highest pain posible
Kujala Score or Anterior Knee Pain Scale (AKPS) on the TRAK platformvisits 1 (week 1) and 5 (week 12) for both goupsSelf-administered patient questionnaire consisting of 13 questions related to specific activities, severity of pain and clinical symptoms. It assesses subjective reactions to particular activities and symptoms that are known to correlate with anterior knee pain syndrome. It is graded from 0 to 100, with 0 being the highest pain severity and 0 the lowest.
Functional Knee Scale KOOS-PS (Knee Injury and Osteoarthritis Outcome Score)visits 1 (week 1) to 5 (week 12) for both goupsis used to assess patient-relevant outcomes following a knee injury. The results range from zero representing extreme knee problems to 100 representing no knee problems.
Patient satisfaction survey on the use of the TRAK PlatformVisit 5 (week 12) on the intervention groupQuestionnaire used on the TRAK platform to measure the patient satisfaction being 0 the worst satisfaction and 12 the best.
EQ-5D-5L Questionnairevisits 1 (week 1) and 5 (week 12) for both goupsQuality of life measurement questionnaire that can be used both in relatively healthy individuals (general population) and in groups of patients with different pathologies. The restults range from 0 to 100, where 100 is the best possible health state and 0 the worst.
Stable gait assessment Y/Nvisits 2 (Week 2) and 5 (Week 12) for both goupsStable running or not depending on the professional's judgement

Countries

Spain

Contacts

Primary ContactJUAN F DUARTE MENDOZA
juanfernando@trak.es+34 677 33 4869
Backup ContactRAÚL ZABALLA FERNÁNDEZ
RAUL.ZABALLAFERNANDEZ@osakidetza.eus+34 946 00 60 00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026